Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANG-First Trial: Angiotensin II in Cardiac Surgery
NCT06487585Phase 4Recruiting
- Sponsor
- University of Maryland St. Joseph Medical Center
- Start
- May 2025
- Primary completion
- Jan 2026
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of Angiotensin II in Vasodilatory shock, sponsored by University of Maryland St. Joseph Medical Center. Started May 2025; status: recruiting.
02
Drugs
Angiotensin II
03
Conditions
Vasodilatory shock
Beyond the preview
Go deeper on NCT06487585.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06487585.